跳到主要內容區塊
卷期標題作者頁數
Volume 33(2025) > Number 3The economic burden of COVID-19 in a region with stringent response measures: A case study of TaiwanElise Chia-Hui Tan, Fei-Yuan Hsiao, Ming-Chin Yang326-338
Volume 33(2025) > Number 3Development and validation of an analytical method for determination of bongkrekic acid in biofluids for toxin monitoringYing-Tzu Shieh, Te-I Weng, Ju-Yu Chen, I-Ting Wang, Kevin Shu-Leung Lai, Chia-Mo Lin, Chu-Yun Teng, Guan-Yuan Chen339-347
Volume 33(2025) > Number 2Aspergillosis: A comprehensive review of pathogenesis, drug resistance, and emerging therapeuticsAmanpreet Singh, Jeewanjot Singh, Sandeep Kumar75-96
Volume 33(2025) > Number 2Regulatory framework and challenges for live biotherapeutic products in TaiwanShirley Pan, Jia-Chuan Hsu, Kuo-Teng Hung, Ching-Jung Ho97-105
Volume 33(2025) > Number 2Jiao San Xian granule containing prebiotic alleviate functional dyspepsia by regulating intestinal flora and the secretion of inflammatory responseHuimin Pei, Mengyuan Zhao, Hongyue Wang, Xindi Zhang, Caihong Shi, Xiangrong Zhang106-118
Volume 33(2025) > Number 2Integrating network analysis and experimental validation to reveal the ferroptosis-associated mechanism of velvet antler in the treatment of chronic atrophic gastritisQuan Liao, Zhenzhen Guo, Chenchun Ding, Renjie Zuo and Guoyan Liu119-131
Volume 33(2025) > Number 2In vitro metabolic profiling of methylenedioxy-substituted synthetic cathinones for enhanced detection in urine sample analysisYa-Ling Yeh, Chin-Lin Hsieh, Yi-Jia Huang, Yu-Hsiang Chang and Sheng-Meng Wang132-149
Volume 33(2025) > Number 2Ping-Chong-Jiang-Ni Formula effectively inhibits migration and invasion of endometriosis 12Z cell line via TRIP13 Jiahua Peng, Shuzhen Liu, Yunxiang Xie, Min Xiao, Chichiu Wang, Ruining Liang150-162
Volume 33(2025) > Number 2Evaluating the cost-effectiveness of atezolizumab-bevacizumab in advanced hepatocellular carcinoma: Insights from TaiwanTsung-Wei Chang, Wei-Chiao Chang, Wan-Hsuan Chou, Wei-Pin Chang, Chun-Nan Kuo163-171
Volume 33(2025) > Number 2Yiqi Yangyin Tongluo prescription targets lncRNA VIM-AS1 to regulate FOXK2/mTOR to promote autophagy and inhibit renal tubular epithelial cell apoptosisRucui Yu, Ruiying Wu, Tingting Chen, Jingwei Xu172-178
2200筆資料, 第2/ 220
最前頁上一頁下一頁最末頁